EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy

Paula Zapata-Cobo iD, Sara Salvador-Martín, Sergio Gil-Manso iD, Marta Velasco Rodríguez-Belvís, Laura M Palomino iD, Ana Moreno-Álvarez iD, Begoña Pérez-Moneo iD, Ruth García-Romero, María J Fobelo iD, Diana García-Tirado iD, César Sánchez, Gemma Pujol-Muncunill und 7 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Paula Zapata-Cobo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Farmacia, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain. Hauptthemen laut MEDLINE: Cytokines, Inflammatory Bowel Diseases, Crohn Disease, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Comunidad de Madrid, “Convocatoria predoctoral Consejería de Educación, ciencia y Universidades de la Comunidad de Madrid”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Failure of anti-TNF therapy is a real concern in children with inflammatory bowel disease (IBD) owing to the limited therapeutic arsenal. Anti-TNF drugs modulate the immune response, a key driver of chronic inflammation in IBD. Accordingly, we analyzed changes in the frequency of T-lymphocyte and cytokine levels after 6 weeks of treatment to identify potential biomarkers of response to anti-TNF drugs. We recruited 77 patients under 18 years of age diagnosed with IBD and treated with an anti-TNF drug. Using flow cytometry and multiplex ELISA, we analyzed 31 T-lymphocyte populations and four cytokines. We identified changes in 10 populations of T lymphocytes after 6 weeks of treatment. Naïve Tregs were associated with a primary response to anti-TNF drugs, while activated Tregs were associated with long-term response. Serum INF-γ levels were decreased after anti-TNF treatment in children with Crohn’s disease (CD), but not in those with ulcerative colitis (UC). The memory CD8+ Type 2 Cytotoxic T (Tc2) subset increased in non-responders with CD and the CD4+ memory Th17 cells increased in non-responders with UC. These findings could help us to understand the cellular regulation of anti-TNF therapy, to identify children at a higher risk of treatment failure, and, potentially, to develop more personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesInflammatory Bowel DiseasesCrohn DiseaseTumor Necrosis Factor-alphaT-LymphocytesTumor Necrosis Factor InhibitorsHumansChildFemaleMaleAdolescentColitis, UlcerativeChild, PreschoolBiomarkersT-Lymphocytes, Regulatory

Stichwörter der Autor:innen

T-lymphocytesTregadalimumabcytokinesinflammatory bowel diseaseinfliximabpediatricresponse biomarkers

Substanzen

CytokinesTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsBiomarkers

Autor:innen und Institutionen

  • Servicio de Farmacia, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.
  • Laboratory of Immuno-Regulation, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.
  • Sección de Gastroenterología y Nutrición Pediátrica, Hospital Infantil Universitario Niño Jesús, 28007 Madrid, Spain.
  • Complejo Hospitalario Universitario A Coruña, 15006 A Coruña, Spain.
  • Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.
  • Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.

ORCID-Profile: Paula Zapata-Cobo, Sergio Gil-Manso, Laura M Palomino, Ana Moreno-Álvarez, Begoña Pérez-Moneo, María J Fobelo, Diana García-Tirado, Oscar Segarra, Rafael Correa-Rocha, Marjorie Pion, Luis A López-Fernández

Förderung

  • Instituto de Salud Carlos III
  • Comunidad de Madrid
  • “Convocatoria predoctoral Consejería de Educación, ciencia y Universidades de la Comunidad de Madrid”
  • ERDF Funds (FEDER) from the European Commission: “A way of making Europe”

Zitieren

APA

Zapata-Cobo, P., Salvador-Martín, S., Gil-Manso, S., Rodríguez-Belvís, M. V., Palomino, L. M., Moreno-Álvarez, A., Pérez-Moneo, B., García-Romero, R., Fobelo, M. J., García-Tirado, D., Sánchez, C., Pujol-Muncunill, G., Segarra, O., Montraveta, M., Magallares, L., Correa-Rocha, R., Sanjurjo-Sáez, M., Pion, M., & López-Fernández, L. A. (2025). Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073323

Vancouver

Zapata-Cobo P, Salvador-Martín S, Gil-Manso S, Rodríguez-Belvís MV, Palomino LM, Moreno-Álvarez A, et al. Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073323

BibTeX
@article{ZapataCobo2025,
  author = {Zapata-Cobo, Paula and Salvador-Martín, Sara and Gil-Manso, Sergio and Rodríguez-Belvís, Marta Velasco and Palomino, Laura M and Moreno-Álvarez, Ana and Pérez-Moneo, Begoña and García-Romero, Ruth and Fobelo, María J and García-Tirado, Diana and Sánchez, César and Pujol-Muncunill, Gemma and Segarra, Oscar and Montraveta, Montserrat and Magallares, Lorena and Correa-Rocha, Rafael and Sanjurjo-Sáez, María and Pion, Marjorie and López-Fernández, Luis A},
  title = {Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073323}
}
Kostenlos starten →